A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells

Chunyan Feng(Tsinghua University), Laiqiang Huang(Tsinghua–Berkeley Shenzhen Institute)
Journal of Experimental & Clinical Cancer Research
January 2, 2024
Cited by 16


Related Papers